Treatment Innovations

Bridging the "Symptom-to-Door" Gap: HeartBeam’s Breakthrough in Portable Heart Attack Detection

• Treatment Innovations

Bridging the "Symptom-to-Door" Gap: HeartBeam’s Breakthrough in Portable Heart Attack Detection

Asro June 4, 2026 0

In a significant advancement for cardiovascular medicine, California-based medical technology firm HeartBeam has unveiled compelling new data...

Read More Read more about Bridging the "Symptom-to-Door" Gap: HeartBeam’s Breakthrough in Portable Heart Attack Detection

Biotech Market Update: Longevity Breakthroughs, Strategic M&A, and Clinical Volatility

• Treatment Innovations

Biotech Market Update: Longevity Breakthroughs, Strategic M&A, and Clinical Volatility

Siti Muinah June 4, 2026 0

The biopharmaceutical landscape continues to evolve at a blistering pace, defined this week by a mix of...

Read More Read more about Biotech Market Update: Longevity Breakthroughs, Strategic M&A, and Clinical Volatility

Medtronic’s Decade-High Growth: A Strategic Deep Dive into the Medtech Giant’s FY26 Performance

• Treatment Innovations

Medtronic’s Decade-High Growth: A Strategic Deep Dive into the Medtech Giant’s FY26 Performance

Lina Hope June 3, 2026 0

In a fiscal landscape defined by rapid technological shifts and increasing demand for advanced medical intervention, Medtronic...

Read More Read more about Medtronic’s Decade-High Growth: A Strategic Deep Dive into the Medtech Giant’s FY26 Performance

Legend Biotech’s In Vivo CAR-T Breakthrough: A Potential Paradigm Shift in Oncology

• Treatment Innovations

Legend Biotech’s In Vivo CAR-T Breakthrough: A Potential Paradigm Shift in Oncology

Nana Wu June 3, 2026 0

By BioPharma Dive Staff Published June 3, 2026 The landscape of cellular immunotherapy is undergoing a tectonic...

Read More Read more about Legend Biotech’s In Vivo CAR-T Breakthrough: A Potential Paradigm Shift in Oncology

Philips Elevates Ultrasound Diagnostics: FDA Clearance and CE Mark Signal New Era in AI-Driven Imaging

• Treatment Innovations

Philips Elevates Ultrasound Diagnostics: FDA Clearance and CE Mark Signal New Era in AI-Driven Imaging

Laily UPN June 3, 2026 0

In a significant advancement for medical imaging technology, Koninklijke Philips N.V. has secured both US Food and...

Read More Read more about Philips Elevates Ultrasound Diagnostics: FDA Clearance and CE Mark Signal New Era in AI-Driven Imaging

Eli Lilly Bets $1.9 Billion on RNA Exon Editing to Tackle Genetic Kidney Disease

• Treatment Innovations

Eli Lilly Bets $1.9 Billion on RNA Exon Editing to Tackle Genetic Kidney Disease

Ali Ikhwan June 3, 2026 0

By Gwendolyn Wu Published June 3, 2026 In a strategic expansion of its genetic medicine portfolio, pharmaceutical...

Read More Read more about Eli Lilly Bets $1.9 Billion on RNA Exon Editing to Tackle Genetic Kidney Disease

Advancing Precision Pacing: MicroPort CardioFlow Launches LBBOT Solution in Europe and Australia

• Treatment Innovations

Advancing Precision Pacing: MicroPort CardioFlow Launches LBBOT Solution in Europe and Australia

Pevita Pearce June 3, 2026 0

In a significant leap forward for electrophysiology and structural heart intervention, MicroPort CardioFlow has officially announced the...

Read More Read more about Advancing Precision Pacing: MicroPort CardioFlow Launches LBBOT Solution in Europe and Australia

Regenerating the Future: Made Scientific Selected to Manufacture Groundbreaking NOVAKnee Biologic Implants

• Treatment Innovations

Regenerating the Future: Made Scientific Selected to Manufacture Groundbreaking NOVAKnee Biologic Implants

Nila Kartika Wati June 3, 2026 0

In a transformative development for the field of orthopaedic medicine, Made Scientific, a premier cell therapy contract...

Read More Read more about Regenerating the Future: Made Scientific Selected to Manufacture Groundbreaking NOVAKnee Biologic Implants

A Paradigm Shift or a Missed Mark? Celcuity’s Gedatolisib Faces Market Skepticism Despite Clinical Success

• Treatment Innovations

A Paradigm Shift or a Missed Mark? Celcuity’s Gedatolisib Faces Market Skepticism Despite Clinical Success

Jia Lissa June 3, 2026 0

In the high-stakes arena of oncology drug development, the divide between clinical significance and Wall Street expectations...

Read More Read more about A Paradigm Shift or a Missed Mark? Celcuity’s Gedatolisib Faces Market Skepticism Despite Clinical Success

A New Dawn in Dermatology: Rubedo’s RLS-1496 Offers Hope for Pain-Free Skin Cancer Prevention

• Treatment Innovations

A New Dawn in Dermatology: Rubedo’s RLS-1496 Offers Hope for Pain-Free Skin Cancer Prevention

Laily UPN June 2, 2026 0

For millions of people worldwide, the diagnosis of actinic keratosis (AK)—the rough, scaly, sun-damaged patches of skin...

Read More Read more about A New Dawn in Dermatology: Rubedo’s RLS-1496 Offers Hope for Pain-Free Skin Cancer Prevention